Viewing Study NCT02676895


Ignite Creation Date: 2025-12-24 @ 2:12 PM
Ignite Modification Date: 2026-01-04 @ 9:23 AM
Study NCT ID: NCT02676895
Status: COMPLETED
Last Update Posted: 2019-02-18
First Post: 2016-02-01
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of the Safety and Immune Response of 2 Doses of a New Shigella Vaccine in Kenyan Adults
Sponsor: GlaxoSmithKline
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2016-08-08
Start Date Type: ACTUAL
Primary Completion Date: 2017-03-10
Primary Completion Date Type: ACTUAL
Completion Date: 2017-03-10
Completion Date Type: ACTUAL
First Submit Date: 2016-02-01
First Submit QC Date: None
Study First Post Date: 2016-02-08
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2018-03-09
Results First Submit QC Date: None
Results First Post Date: 2019-02-18
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2018-10-08
Last Update Post Date: 2019-02-18
Last Update Post Date Type: ACTUAL